St Louis Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $558K | Hold |
53,894
| – | – | 0.06% | 93 |
|
|
2026
Q1 | $1.51M | Buy |
53,894
+423
| +0.8% | +$11.3K | 0.18% | 69 |
|
|
2025
Q4 | $1.33M | Buy |
+53,471
| New | +$1.35M | 0.15% | 72 |
|
|
2023
Q1 | – | Sell |
-4,121
| Closed | -$211K | – | 102 |
|
|
2022
Q4 | $211K | Buy |
+4,121
| New | +$198K | 0.04% | 101 |
|
|
2022
Q3 | – | Sell |
-4,121
| Closed | -$216K | – | 98 |
|
|
2022
Q2 | $216K | Hold |
4,121
| – | – | 0.05% | 96 |
|
|
2022
Q1 | $213K | Hold |
4,121
| – | – | 0.05% | 96 |
|
|
2021
Q4 | $243K | Buy |
+4,121
| New | +$204K | 0.05% | 103 |
|
|
2021
Q3 | – | Sell |
-7,904
| Closed | -$310K | – | 108 |
|
|
2021
Q2 | $310K | Hold |
7,904
| – | – | 0.08% | 82 |
|
|
2021
Q1 | $286K | Buy |
7,904
+150
| +2% | +$5.33K | 0.07% | 84 |
|
|
2020
Q4 | $285K | Sell |
7,754
-419
| -5% | -$15.4K | 0.08% | 70 |
|
|
2020
Q3 | $285K | Hold |
8,173
| – | – | 0.09% | 78 |
|
|
2020
Q2 | $253K | Hold |
8,173
| – | – | 0.08% | 79 |
|
|
2020
Q1 | $253K | Hold |
8,173
| – | – | 0.1% | 74 |
|
|
2019
Q4 | $304K | Hold |
8,173
| – | – | 0.09% | 71 |
|
|
2019
Q3 | $278K | Sell |
8,173
-598
| -7% | -$21.7K | 0.09% | 71 |
|
|
2019
Q2 | $361K | Hold |
8,771
| – | – | 0.11% | 67 |
|
|
2019
Q1 | $353K | Hold |
8,771
| – | – | 0.11% | 66 |
|
|
2018
Q4 | $363K | Hold |
8,771
| – | – | 0.13% | 65 |
|
|
2018
Q3 | $367K | Sell |
8,771
-8,665
| -50% | -$334K | 0.13% | 67 |
|
|
2018
Q2 | $600K | Sell |
17,436
-9,116
| -34% | -$312K | 0.2% | 66 |
|
|
2018
Q1 | $894K | Sell |
26,552
-4,786
| -15% | -$165K | 0.31% | 60 |
|
|
2017
Q4 | $1.08M | Buy |
31,338
+17,781
| +131% | +$606K | 0.42% | 33 |
|
|
2017
Q3 | $459K | Hold |
13,557
| – | – | 0.2% | 42 |
|
|
2017
Q2 | $432K | Hold |
13,557
| – | – | 0.2% | 42 |
|
|
2017
Q1 | $440K | Hold |
13,557
| – | – | 0.19% | 42 |
|
|
2016
Q4 | $418K | Sell |
13,557
-316
| -2% | -$9.65K | 0.2% | 40 |
|
|
2016
Q3 | $445K | Sell |
13,873
-996
| -7% | -$33.3K | 0.21% | 38 |
|
|
2016
Q2 | $497K | Sell |
14,869
-4,979
| -25% | -$159K | 0.26% | 33 |
|
|
2016
Q1 | $558K | Buy |
19,848
+2,905
| +17% | +$83K | 0.3% | 33 |
|
|
2015
Q4 | $519K | Buy |
+16,943
| New | +$533K | 0.33% | 33 |
|
Other funds holding PFE
St Louis Trust's PFE Position: Q2 2026 in Review
St Louis Trust held its Pfizer (PFE) position steady in Q2 2026 at 53,894 shares worth $558K. The position accounts for 0.06% of the portfolio, ranked #93.
St Louis Trust first reported a position in PFE in Q4 2015 and has held it in 30 quarters since. The position peaked at $1.51M in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- St Louis Trust held 53,894 shares of Pfizer worth $558K as of Q2 2026.
- St Louis Trust left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up 0.06% of St Louis Trust's portfolio in Q2 2026, its #93 holding.
- St Louis Trust first reported a position in Pfizer in Q4 2015 and has held it in 30 quarters since.
- St Louis Trust's Pfizer position peaked at $1.51M in Q1 2026.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on St Louis Trust's 13F filing for Q2 2026, filed 30 Jul 2026.